Stockscreener 앱 받기
0.6422
0.34%
-0.0022
시간 외 거래:
.65
0.0078
+1.21%
전일 마감가:
$0.6444
열려 있는:
$0.641
하루 거래량:
354.83K
Relative Volume:
0.40
시가총액:
$31.17M
수익:
$19.94M
순이익/손실:
$-37.37M
주가수익비율:
-0.6175
EPS:
-1.04
순현금흐름:
$-33.38M
1주 성능:
+5.05%
1개월 성능:
-32.52%
6개월 성능:
-39.98%
1년 성능:
-60.36%
1일 변동 폭
$0.64
$0.67
1주일 범위
$0.60
$0.67
52주 변동 폭
$0.5588
$2.38
웨어울프 테라 Stock (HOWL) Company Profile
명칭
Werewolf Therapeutics Inc
전화
617-952-0555
주소
200 TALCOTT AVENUE, WATERTOWN
HOWL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.6422 | 31.28M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
웨어울프 테라 Stock (HOWL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-04-03 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-24 | 개시 | Wedbush | Outperform |
| 2023-06-06 | 재개 | Jefferies | Buy |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-05-25 | 개시 | Evercore ISI | Outperform |
| 2021-05-25 | 개시 | H.C. Wainwright | Buy |
| 2021-05-25 | 개시 | Jefferies | Buy |
| 2021-05-25 | 개시 | SVB Leerink | Outperform |
모두보기
웨어울프 테라 주식(HOWL)의 최신 뉴스
Luke Evnin Sells 34,847 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
Will Werewolf Therapeutics Inc. stock return to pre crisis levelsAnalyst Upgrades & Capital Efficiency Improvement - bollywoodhelpline.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Receives Consensus Rating of “Hold” from Analysts - Defense World
Market Moves: Is Werewolf Therapeutics Inc. stock ready for breakoutWeekly Trade Summary & Real-Time Stock Price Movement Reports - moha.gov.vn
Will Werewolf Therapeutics Inc. stock benefit from infrastructure spendingProduct Launch & Free Accurate Trade Setup Notifications - Улправда
Is Werewolf Therapeutics Inc. stock ready for breakoutJuly 2025 Big Picture & AI Optimized Trading Strategy Guides - Улправда
Werewolf Therapeutics (NASDAQ:HOWL) Downgraded to “Neutral” Rating by Wedbush - Defense World
Why retail investors pile into Werewolf Therapeutics Inc. stockRisk Management & Technical Confirmation Trade Alerts - Улправда
HC Wainwright & Co. Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - Nasdaq
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update By Investing.com - Investing.com Nigeria
Can Werewolf Therapeutics Inc. stock hit analyst price targetsOil Prices & Capital Protection Trading Alerts - DonanımHaber
Wedbush Downgrades Werewolf Therapeutics to Neutral From Outperform Due to 'Forward Challenging' Path, Cuts Price Target to $1 From $3 - marketscreener.com
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update - Investing.com Nigeria
Werewolf Therapeutics advances Inducer platform candidates - BioWorld MedTech
Werewolf Therapeutics Announces Pipeline and Business Updates - Investing News Network
Werewolf Therapeutics Updates Pipeline and Outlines 2026 Priorities - TipRanks
Werewolf Therapeutics Incplans for two INDs by mid-2027 - marketscreener.com
Werewolf Therapeutics, Inc. Announces Pipeline Update and 2026 Priorities - TradingView — Track All Markets
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 14,548 Shares of Stock - MarketBeat
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 9,983 Shares of Stock - MarketBeat
Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why - MSN
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know - sharewise.com
What analysts say about Werewolf Therapeutics Inc stockInsider Trading Activity & Free Superior Stock Performance - earlytimes.in
Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 17,858 Shares - MarketBeat
Luke Evnin Sells 37,104 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Director Sells $29,969.63 in Stock - MarketBeat
Werewolf Therapeutics, Inc. (HOWL) director discloses Rule 10b5-1 stock sales - Stock Titan
IPO Launch: What is the fair value of Werewolf Therapeutics Inc stock nowWeekly Investment Report & Momentum Based Trading Signals - moha.gov.vn
How Werewolf Therapeutics Inc. stock benefits from global expansionEarnings Summary Report & Expert Curated Trade Setup Alerts - Newser
What is the fair value of Werewolf Therapeutics Inc. stock nowStop Loss & Daily Profit Maximizing Tips - Newser
Werewolf Therapeutics (HOWL) former 10% owners sell $183k in stock - Investing.com India
MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k - Investing.com India
MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k By Investing.com - Investing.com Australia
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $117k - Investing.com
A new trading data show Werewolf Therapeutics Inc (HOWL) is showing positive returns. - Setenews
Owner MPM BioVentures 2014 LP Files To Sell 130,125 Of Werewolf Therapeutics Inc [HOWL] - TradingView — Track All Markets
Will Werewolf Therapeutics Inc. stock benefit from green energy trends - Newser
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $115k By Investing.com - Investing.com India
Werewolf Therapeutics (HOWL) 10% owners sell $179k in stock By Investing.com - Investing.com Australia
웨어울프 테라 (HOWL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):